We are a clinical-stage pharmaceutical company focused on the discovery and development of human therapeutics to fill unmet medical needs. Our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. We have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, and cancer.


 

RECENT HIGHLIGHTS

First Liver-Selective Glucokinase Activator for Type 2 Diabetes Demonstrates Normalized HbA1c and No Hypoglycemia in Clinical Trial
More Information


TransTech Pharma Completes End of Phase 2 Meeting with FDA for TTP488
More Information

 

Home   |   About Us   |   Therapeutic Areas   |   Discovery Platform   |   Strategic Alliances   |   Press Releases    |   Careers    |   Contact Us    |   Login
© Copyright 2013, TransTech Pharma, LLC., all rights reserved. ® Marks owned by TransTech Pharma, LLC.
Web Design and Development by BEM Interactive